Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives-Reference-Cited by-同舟云学术

Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives

Published:2014-09 Issue:18 Volume:24 Page:4568-4574
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Rondanin Riccardo,Simoni Daniele,Romagnoli Romeo,Baruchello Riccardo,Marchetti Paolo,Costantini Cristiana,Fochi Sara,Padroni Giacomo,Grimaudo Stefania,Pipitone Rosaria Maria,Meli Maria,Tolomeo Manlio

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference23 articles.

1. JAKs, STATs and Src kinases in hematopoiesis

2. Signal transducer and activator of transcription 5 (STAT5)

3. The Stat family in cytokine signaling

4. STATs: transcriptional control and biological impact

5. Stat5 is indispensable for the maintenance of bcr/abl ‐positive leukaemia

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells;Journal of Interferon & Cytokine Research;2024-04-01

2. Targeting STAT5B in T-cell acute lymphoblastic leukemia;Blood;2023-07-20

3. Substituent Effects on the Carboxylation Step of Allyllic Substrates: A Density Functional Theory Study;ChemistrySelect;2023-05-22

4. Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer;Neuroscience & Biobehavioral Reviews;2022-10

5. STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells;Journal of Biomolecular Structure and Dynamics;2021-11-28